P. Masaryk

2.0k total citations
17 papers, 579 citations indexed

About

P. Masaryk is a scholar working on Orthopedics and Sports Medicine, Rheumatology and Surgery. According to data from OpenAlex, P. Masaryk has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Orthopedics and Sports Medicine, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in P. Masaryk's work include Bone health and osteoporosis research (7 papers), Vitamin D Research Studies (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). P. Masaryk is often cited by papers focused on Bone health and osteoporosis research (7 papers), Vitamin D Research Studies (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). P. Masaryk collaborates with scholars based in Slovakia, Germany and Hungary. P. Masaryk's co-authors include Alan J. Silman, Christa Scheidt‐Nave, L I Benevolenskaya, Mark Lunt, Jorge B. Cannata‐Andía, Dieter Felsenberg, K. Weber, J. Reeve, D M Reid and Huibert A. P. Pols and has published in prestigious journals such as Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases and Osteoporosis International.

In The Last Decade

P. Masaryk

16 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Masaryk Slovakia	7	370	165	119	103	90	17	579
L I Benevolenskaya Belgium	8	384 1.0×	171 1.0×	128 1.1×	98 1.0×	63 0.7×	17	521
Martha C. Castaño‐Betancourt Netherlands	10	306 0.8×	210 1.3×	137 1.2×	159 1.5×	165 1.8×	16	636
Shigehito Miyamoto Japan	6	352 1.0×	144 0.9×	218 1.8×	152 1.5×	66 0.7×	7	620
G. Kapetanos Greece	12	246 0.7×	219 1.3×	130 1.1×	116 1.1×	45 0.5×	25	526
Sarah Hardcastle United Kingdom	12	188 0.5×	146 0.9×	77 0.6×	122 1.2×	163 1.8×	19	522
Halley Rogers United States	7	380 1.0×	148 0.9×	139 1.2×	145 1.4×	36 0.4×	9	524
Fredrik Nyquist Sweden	15	412 1.1×	315 1.9×	75 0.6×	71 0.7×	152 1.7×	17	692
J. Dequeker Belgium	10	387 1.0×	89 0.5×	136 1.1×	171 1.7×	141 1.6×	11	663
A. Rezqi Morocco	13	393 1.1×	167 1.0×	49 0.4×	74 0.7×	233 2.6×	16	589
Xian-Ping Wu China	9	286 0.8×	95 0.6×	101 0.8×	185 1.8×	30 0.3×	20	481

Countries citing papers authored by P. Masaryk

Since Specialization

Citations

This map shows the geographic impact of P. Masaryk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Masaryk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Masaryk more than expected).

Fields of papers citing papers by P. Masaryk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Masaryk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Masaryk. The network helps show where P. Masaryk may publish in the future.

Co-authorship network of co-authors of P. Masaryk

This figure shows the co-authorship network connecting the top 25 collaborators of P. Masaryk. A scholar is included among the top collaborators of P. Masaryk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Masaryk. P. Masaryk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Boers, Maarten, Linda Hartman, Daniela Opriș-Belinski, et al.. (2023). Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the Rheumatic Diseases. 82(10). 1307–1314. 9 indexed citations

Boers, Maarten, Linda Hartman, Daniela Opriș-Belinski, et al.. (2022). Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the Rheumatic Diseases. 81(7). 925–936. 83 indexed citations

Hartman, Linda, Mohamed El Alili, Maurizio Cutolo, et al.. (2022). Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial. Seminars in Arthritis and Rheumatism. 57. 152109–152109. 3 indexed citations

Masaryk, P., et al.. (2018). The Experience of the State of Flow in Brazilian Jiu-Jitsu. 18(3). 1–6. 4 indexed citations

Ivergård, M, A Svedbom, E Hernlund, et al.. (2013). Epidemiology and Economic Burden of Osteoporosis in Slovakia. Archives of Osteoporosis. 8.

Vaňuga, Peter, et al.. (2009). Vitamin D levels in young healtly premenopausal females in Slovakia. 20(49). e2402799–e2402799. 1 indexed citations

Masaryk, P., et al.. (2006). [Gastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: results of one-year prospective study].. PubMed. 52(7-8). 673–6. 2 indexed citations

Rovenský, J, et al.. (2004). [Seroprevalence of Helicobacter pylori in rheumatoid arthritis and its relationship to pharmacotherapy].. PubMed. 50(12). 911–6. 4 indexed citations

Stancíková, M, et al.. (2003). Eggshell calcium in the prevention and treatment of osteoporosis.. PubMed. 23(2-3). 83–92. 48 indexed citations

10.

Lunt, Mark, P. Masaryk, Christa Scheidt‐Nave, et al.. (2001). The Effects of Lifestyle, Dietary Dairy Intake and Diabetes on Bone Density and Vertebral Deformity Prevalence: The EVOS Study. Osteoporosis International. 12(8). 688–698. 119 indexed citations

11.

Masaryk, P., et al.. (2001). Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.. PubMed. 21(3-4). 119–25. 3 indexed citations

12.

Payer, Juraj, et al.. (2000). [Effect of alendronate therapy on bone turnover--results of a multicenter study].. PubMed. 46(10). 689–92. 1 indexed citations

13.

Masaryk, P., Mark Lunt, L I Benevolenskaya, et al.. (1998). Effects of Menstrual History and Use of Medications on Bone Mineral Density: The EVOS Study. Calcified Tissue International. 63(4). 271–276. 16 indexed citations

14.

Lunt, Mark, Dieter Felsenberg, J.E. Adams, et al.. (1997). Population-based geographic variations in dxa bone density in Europe: The evos study. Osteoporosis International. 7(3). 175–189. 129 indexed citations

15.

Lunt, Mark, Dieter Felsenberg, J. Reeve, et al.. (1997). Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study. Journal of Bone and Mineral Research. 12(11). 1883–1894. 152 indexed citations

16.

Stancíková, M, et al.. (1996). Effect of biomin H on the biochemical markers of osteoporosis in postmenopausal women. Osteoporosis International. 6(S1). 267–267. 3 indexed citations

17.

Stancíková, M, et al.. (1996). Effect of biomin H and vitamin D2 on the ovariectomized rats. Osteoporosis International. 6(S1). 266–266. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact